The pathway of isolated seminal vesicle invasion has a different impact on biochemical recurrence after radical prostatectomy and pelvic lymphadenectomy.

[1]  Henk G van der Poel,et al.  EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer. , 2020, European urology.

[2]  F. Montorsi,et al.  Added Clinical Value of Whole-mount Histopathology of Radical Prostatectomy Specimens: A Collaborative Review. , 2020, European urology oncology.

[3]  R. Fisher,et al.  A Phase III Multi-Centre Randomised Trial comparing adjuvant versus early salvage Radiotherapy following a Radical Prostatectomy: Results of the TROG 08.03 and ANZUP “RAVES” Trial , 2019, International Journal of Radiation Oncology*Biology*Physics.

[4]  H. G. van der Poel,et al.  EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. , 2017, European urology.

[5]  F. Montorsi,et al.  Prostate cancer: from Gleason scoring to prognostic grade grouping , 2016, Expert review of anticancer therapy.

[6]  F. Montorsi,et al.  Total submission of lymphadenectomy tissues removed during radical prostatectomy for prostate cancer: possible clinical significance of large-format histology. , 2014, Human pathology.

[7]  N. Willich,et al.  Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96-02/AUO AP 09/95 trial. , 2014, European urology.

[8]  L. Egevad,et al.  Prognostic significance of patterns of seminal vesicle invasion in prostate cancer , 2013, Histopathology.

[9]  M. Terris,et al.  Natural history of persistently elevated prostate specific antigen after radical prostatectomy: results from the SEARCH database. , 2009, The Journal of urology.

[10]  E. Messing,et al.  Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial. , 2009, The Journal of urology.

[11]  Richard K Valicenti,et al.  Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  U. Ferreira,et al.  Seminal vesicle invasion in radical prostatectomies: Which is the most common route of invasion? , 2007, International Urology and Nephrology.

[13]  P. Scardino,et al.  Cancer‐specific survival and predictors of prostate‐specific antigen recurrence and survival in patients with seminal vesicle invasion after radical prostatectomy , 2006, Cancer.

[14]  A. Partin,et al.  Adenocarcinoma of the prostate invading the seminal vesicle: prognostic stratification based on pathologic parameters. , 2000, Urology.

[15]  P. Scardino,et al.  The Mechanisms and Prognostic Significance of Seminal Vesicle Involvement by Prostate Cancer , 1993, The American journal of surgical pathology.

[16]  P. Walsh,et al.  Adenocarcinoma of the prostate invading the seminal vesicle: definition and relation of tumor volume, grade and margins of resection to prognosis. , 1993, The Journal of urology.

[17]  T. Stamey,et al.  Pathogenesis and biological significance of seminal vesicle invasion in prostatic adenocarcinoma. , 1990, The Journal of urology.

[18]  Lars Egevad,et al.  International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 1: specimen handling , 2011, Modern Pathology.

[19]  B. Delahunt,et al.  International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 4: seminal vesicles and lymph nodes , 2011, Modern Pathology.